Forte Biosciences prices $75M public offering of stock and warrants

Forte Biosciences, Inc.

Priced 5,630,450 shares at $12.00/share and 619,606 pre-funded warrants at $11.999/warrant.
Gross proceeds expected ~$75M; net ~$70M (or ~$80.5M if underwriters' option exercised).
Proceeds for working capital, general corporate purposes, funding clinical/preclinical development.
Offering expected to close June 26, 2025, subject to customary closing conditions.
Underwriters granted 30-day option to purchase up to 937,508 additional shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.